Business Segments West Pharmaceutical Services, Inc.
Equities
WST
US9553061055
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
297.24 USD | -1.02% | -5.23% | -15.59% |
Sales 2023 by Business Segment
Sales 2023 by Geography
Historical Breakdown of Revenue by Business Segments
Operating Income: Breakdown by Business Segment
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Life Sciences Tools and Services | ||||||||||
Proprietary Products | 1.4B | 1.65B | 2.32B | 2.41B | 2.4B | |||||
Total Assets | 1.48B | 1.8B | 2.15B | 2.58B | 2.63B | |||||
CAPEX | -91.2M | -140M | -218M | -237M | -259M | |||||
Gross Profit | 540M | 682M | 1.09B | 1.05B | 1.03B | |||||
D&A | 82.2M | 84.6M | 93.8M | 96.9M | 113M | |||||
Operating Income | 314M | 434M | 796M | 784M | 710M | |||||
Medical Instruments | ||||||||||
Contract-Manufactured Products | 442M | 499M | 515M | 480M | 552M | |||||
Total Assets | 386M | 412M | 444M | 480M | 528M | |||||
CAPEX | -37.2M | -25M | -26.6M | -34M | -90.2M | |||||
Gross Profit | 65.5M | 85.6M | 83.8M | 82.9M | 96M | |||||
D&A | 17.9M | 20.4M | 21.1M | 19M | 20.4M | |||||
Operating Income | 49.1M | 68.6M | 67.2M | 60.4M | 72.1M | |||||
Pharmaceutical Packaging Systems | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Gross Profit | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Medical Consumables | ||||||||||
Pharmaceutical Delivery Systems | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Gross Profit | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - | |||||
Eliminations | -200K | -300K | -400K | -300K | - | |||||
Total Assets | 475M | 584M | 718M | 558M | 673M | |||||
CAPEX | 2M | -9.9M | -8.8M | -13.3M | -12.7M | |||||
D&A | 3.3M | 4.1M | 7.4M | 4.7M | 4M | |||||
Operating Income | -66.3M | - | - | - | - | |||||
Operating Income | - | -34M | -37.5M | -23.7M | -23.3M | |||||
Operating Income | - | -52.1M | -63.4M | -59.1M | -68.3M | |||||
Gross Profit | -200K | - | -1.9M | - | -800K |
Geographical Revenue Distribution History
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
United States | 815M | 976M | 1.2B | 1.29B | 1.24B | |||||
Total Assets | 337M | 408M | 504M | 612M | 757M | |||||
Germany | 236M | 282M | 474M | 399M | 406M | |||||
Total Assets | 95.4M | 112M | 124M | 139M | 176M | |||||
Other European Countries | 251M | 237M | 341M | 359M | 388M | |||||
Total Assets | 59.1M | 66.8M | 65.1M | 81.8M | 99.2M | |||||
Other | 213M | 254M | 357M | 364M | 348M | |||||
Total Assets | 132M | 151M | 160M | 182M | 195M | |||||
Ireland | 174M | 226M | 248M | 240M | 286M | |||||
Total Assets | 162M | 198M | 187M | 180M | 207M | |||||
France | 151M | 173M | 213M | 238M | 283M | |||||
Total Assets | 53.3M | 76M | 86.1M | 68.8M | 78.5M |
- Stock Market
- Equities
- WST Stock
- Financials West Pharmaceutical Services, Inc.
- Business Segments
MarketScreener is also available in this country: United States.
Switch edition